v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
May 31, 2025
May 31, 2024
May 31, 2023
Cash Flows From Operating Activities:      
Net Income $ 690,327 $ 589,442 $ 479,731
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 193,840 171,251 154,949
Goodwill impairment 11,352 0 36,745
Deferred income taxes (104,507) (5,638) 6,236
Stock-based compensation expense 27,042 25,925 28,673
Net (gain) loss on marketable securities (4,997) (19,914) 2,086
Net (gain) on sales of assets and businesses 0 (971) (28,632)
Other 1,269 2,226 1,683
Changes in assets and liabilities, net of effect from purchases and sales of businesses:      
(Increase) decrease in receivables (55,037) 82,895 (94,585)
(Increase) decrease in inventory (34,458) 179,843 66,805
(Increase) decrease in prepaid expenses and other current and long-term assets (62,669) 23,426 1,364
Increase (decrease) in accounts payable 84,074 (24,439) (116,053)
(Decrease) increase in accrued compensation and benefits (17,130) 39,891 (2,643)
Increase in accrued losses 3,899 5,958 2,231
Increase in other accrued liabilities 35,185 52,410 38,515
Cash Provided By Operating Activities 768,190 1,122,305 577,105
Cash Flows From Investing Activities:      
Capital expenditures (229,930) (213,970) (254,435)
Acquisition of businesses, net of cash acquired (595,770) (15,549) (47,542)
Purchase of marketable securities (85,793) (32,981) (18,674)
Proceeds from sales of marketable securities 87,093 46,689 12,731
Proceeds from sales of assets and businesses 0 6,921 58,288
Other (1,134) 2,450 (72)
Cash (Used For) Investing Activities (825,534) (206,440) (249,704)
Cash Flows From Financing Activities:      
Additions to long-term and short-term debt 478,111 0 341,720
Reductions of long-term and short-term debt (9,008) (575,408) (355,463)
Cash dividends (255,563) (231,883) (213,912)
Repurchase of common stock (69,999) (54,978) (50,000)
Shares of common stock returned for taxes (18,686) (24,548) (17,047)
Payments of acquisition-related contingent consideration (1,122) (1,142) (3,765)
Other (1,796) (2,075) (2,689)
Cash Provided By (Used For) Financing Activities 121,937 (890,034) (301,156)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 165 (4,239) (12,130)
Net Change in Cash and Cash Equivalents 64,758 21,592 14,115
Cash and Cash Equivalents at Beginning of Period 237,379 215,787 201,672
Cash and Cash Equivalents at End of Period 302,137 237,379 215,787
Cash paid during the year for:      
Interest 93,460 116,650 113,953
Income taxes, net of refunds 204,255 203,607 134,436
Supplemental Disclosures of Non-Cash Investing and Financing Activities:      
Capital expenditures accrued within accounts payable at year-end $ 24,673 $ 24,632 $ 34,470